Drug induced dystonia tarda: treatment with L-dopa.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D002746:Chlorpromazine / Q000009:adverse effects / Q000627:therapeutic use; D002908:Chronic Disease; D003975:Diazepam / Q000009:adverse effects* / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004422:Dystonia Musculorum Deformans / Q000139:chemically induced / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*; D013881:Thioridazine / Q000009:adverse effects / Q000627:therapeutic use; D014268:Trifluoperazine / Q000009:adverse effects / Q000627:therapeutic use
D014150:Antipsychotic Agents; D014268:Trifluoperazine; D004295:Dihydroxyphenylalanine; D013881:Thioridazine; D003975:Diazepam; D002746:Chlorpromazine